4.3 Article

A novel CDPK1 inhibitor-a potential treatment for cryptosporidiosis in calves?

期刊

PARASITOLOGY RESEARCH
卷 114, 期 1, 页码 335-336

出版社

SPRINGER
DOI: 10.1007/s00436-014-4228-7

关键词

Cryptosporidium parvum; Cryptosporidiosis; Treatment; CDPK1; Bumped kinase inhibitor

向作者/读者索取更多资源

Cryptosporidium parvum is a zoonotic agent that infects humans and animals occasionally causing severe, watery diarrhoea. In immunocompetent hosts, cryptosporidiosis is self-limiting but can have a fatal outcome in immunocompromised individuals. Cryptosporidium is one of the most common causes of waterborne diseases (recreational water and drinking water) in humans, a leading cause of moderate to severe childhood diarrhoea, and a major agent of diarrhoea in calves leading to high economic losses and up to 10 % lethality. So far, available treatment options are insufficient for both veterinary and human clinical disease cases. Here, we report for the first time that the novel bumped kinase inhibitor (BKI) 1294 targeting the calcium-dependent protein kinase 1 (CDPK1) of Cryptosporidium is able to reduce the oocyst shedding of C. parvum by calves-its natural host-without obvious side effects.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据